Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 4:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 1,602 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Skin Patch Clear all

Conditions: Down Syndrome, Mild Cognitive Impairment
Interventions: Low Dose Nicotine (7mg), Moderate Dose Nicotine (14mg); Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 25 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Wound Healing, Wound Infection
Interventions: Procellera™ Antimicrobial Wound Dressing, ACTICOAT™ Antimicrobial Barrier Dressing, Mepilex® Ag Silver Foam Dressing; Device · Drug
Lead sponsor: Vomaris Innovations; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Oro Valley, Arizona • Tucson, Arizona

Conditions: Contraception, Adolescent Behavior, Emergency Department
Interventions: Multi-Level Intervention, Enhanced Standard of Care; Behavioral
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 15 Years to 18 Years · Female only
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Kansas City, Missouri • Philadelphia, Pennsylvania

Conditions: Actinic Keratosis
Interventions: 5-fluorouracil 5% cream, Calcipotriol 0.005% ointment, Vaseline; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 50 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Type1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Interventions: LabPatch Continuous Glucose Monitoring (CGM); Device
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Schizophrenia, Schizoaffective Disorder, Cognitive Impairment, Visual Impairment
Interventions: Perceptual Discrimination Training, Cognitive Control Training; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 79 Years
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Epicondylitis of the Elbow
Interventions: Naproxen, Synera patch twice daily, Synera patch for 12hrs/day, Synera; Drug
Lead sponsor: International Clinical Research Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Cognitive Impairment, Estrogen Deficiency, Menopause, Endothelial Dysfunction, Vascular Stiffness
Interventions: GnRHant + E2, GnRHant + Placebo; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Aurora, Colorado • Boulder, Colorado

Conditions: Postoperative Pain
Interventions: Buprenorphine transdermal patch, Placebo BTDS; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 5
States / cities: Phoenix, Arizona • San Clemente, California • Orlando, Florida + 2 more

Conditions: Healthy Volunteers
Interventions: abaloparatide-sMTS, abaloparatide-SC; Combination Product
Lead sponsor: Radius Health, Inc.; Industry
Eligibility: 40 Years to 65 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Atopic Dermatitis
Interventions: Skin tape strips; Other
Lead sponsor: National Jewish Health; Other
Eligibility: 4 Years to 12 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction, Cardiovascular Disease
Interventions: Leuprolide acetate, Estradiol, Medroxyprogesterone, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years to 60 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Aurora, Colorado • Boulder, Colorado

Conditions: Advanced Cancers, Malignant Pleural Effusions
Interventions: Questionnaires, Fentanyl Patch, Fentanyl (IV), Saline, Doxycycline, Phone Calls; Behavioral · Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Nicotine Dependence
Interventions: varenicline, transdermal nicotine patch; Drug · Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Menopause, Arteriosclerosis
Interventions: Conjugated equine estrogens 0.45 mg/day, Transdermal estradiol, 50 mcg/day, Micronized progesterone, 200 mg/day x 12 d/month, CEE , progesterone, estradiol patch or placebo for each, CEE, progesterone, transdermal patch or the placebo; Drug
Lead sponsor: Kronos Longevity Research Institute; Other
Eligibility: 42 Years to 58 Years · Female only
Enrollment: 728 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2012
U.S. locations: 9
States / cities: Phoenix, Arizona • San Francisco, California • New Haven, Connecticut + 6 more

Conditions: Heart Failure
Interventions: C-Pulse® System Counterpulsation; Device
Lead sponsor: Nuwellis, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 28
States / cities: Birmingham, Alabama • Los Angeles, California • San Francisco, California + 24 more

Conditions: Healthy
Interventions: EMSAM (Selegiline Transdermal System) 6mg/24Hr, EMSAM (Selegiline Transdermal System) 9mg/24Hr, EMSAM (Selegiline Transdermal System) 12mg/24hr; Drug
Lead sponsor: Somerset Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 2
States / cities: Scottsdale, Arizona • St. Petersburg, Florida

Conditions: Smoking Cessation
Interventions: Stepped-Care, Control; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Walnut Creek, California

Conditions: Osteoarthritis of the Knee
Interventions: Lidoderm (Lidocaine 5% Patch), Placebo Patch; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 37 Years and older
Enrollment: 169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 20
States / cities: Paradise Valley, Arizona • Phoenix, Arizona • Milford, Connecticut + 16 more

Conditions: Effects of Heat, Tolerability, Adhesiveness, Dermal Irritation
Interventions: Thermal Adhesion Patch, Marketed Thermal Adhesion Patch, Placebo Patch; Device
Lead sponsor: Chattem, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Pinellas Park, Florida

Conditions: Device Latency
Interventions: MIND1 System; Device
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Walnut Creek, California

Conditions: Wound Healing
Interventions: Procellera™ Wound Dressing with V.A.C.® Therapy, V.A.C.® Therapy; Device
Lead sponsor: Vomaris Innovations; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Age-Related Memory Disorders
Interventions: Transdermal nicotine patch, Placebo transdermal patch; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 55 Years to 90 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Durham, North Carolina • Burlington, Vermont

Conditions: Spina Bifida; Fetus, Myelomeningocele, Myeloschisis
Interventions: NEOX Cord 1K applied fetoscopically; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2036
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Nicotine Treatment of Cognitive Decline in Down Syndrome

Efficacy Study of a Bioelectric Dressing to Treat Wounds Caused by Curettage and Electrodesiccation

Reducing Adolescent Pregnancy in the Emergency Department

Actinic Keratosis Study

PRECISION Study: Evaluating the Accuracy of the LabPatch Continuous Glucose Monitor

NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia

Study to Evaluate the Efficacy of the Synera Patch Compared to Naproxen Sodium for Epicondylitis of the Elbow

Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function

Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement

Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.

Skin Tape Transcriptome Methods in Children

Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women

Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis

Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity

Kronos Early Estrogen Prevention Study (KEEPS)

C-Pulse® System: A Heart Assist Device Clinical Study

Evaluation of Adhesion and Dermal Tolerability of EMSAM

Interventions for Smoking Among Persons in Recovery

Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee

Evaluation of Experimental Heat Patch

Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)

Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers

Nicotine Treatment of Mild Cognitive Impairment (MCI)

Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair